Clinical Trials Browser

INDUSTRY × Interventional × Photochemotherapy × Clear all

Prostatic Neoplasms

NCT00472459 2025-04-18

Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer

Phase 3 Completed

82 enrolled 20 charts

Dermatologic

Bowen's Disease, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Warts, Keratosis, Actinic

NCT00472108 2024-08-05

Photodynamic Therapy (PDT) With Metvix Cream 160 mg/g Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Cell Carcinoma

Phase 3 Completed

65 enrolled 15 charts

Dermatologic

Carcinoma, Basal Cell

NCT01966120 2023-07-28

Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)

Phase 3 Completed

87 enrolled 21 charts

Dermatologic

Keratosis, Actinic

NCT00306800 2021-02-18

Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp

Phase 3 Completed

80 enrolled

Dermatologic

Keratosis, Actinic

NCT03053635 2018-08-20

Intravesical Photodynamic Therapy (PDT) in BCG Refractory High-Risk Non-muscle Invasive Bladder Cancer (NMIBC) Patients

Phase 1 Completed

6 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Carcinoma, Transitional Cell

NCT02628236 2017-09-18

Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)

Phase 2 Completed

14 enrolled 39 charts

Dermatologic

Keratosis, Actinic

NCT02281136 2017-01-13

Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick

Phase 2 Completed

29 enrolled 34 charts

Dermatologic

Keratosis, Actinic

NCT00308854 2008-04-11

Photodynamic Therapy With PD P 506 A Compared With Placebo-PDT for the Treatment of AK

Phase 3 Completed

107 enrolled

Dermatologic

Keratosis, Actinic

NCT00308867 2008-04-11

PD P 506 A-PDT Versus Placebo-PDT and Cryosurgery for the Treatment of AK

Phase 3 Completed

349 enrolled

Dermatologic

Keratosis, Actinic

NCT00122876 2007-12-07

Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)

Phase 1/2 Completed

25 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00083785 2007-04-11

Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases

Phase 2 Completed

25 enrolled

Gastrointestinal

Liver Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT00068068 2006-09-19

Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases

Phase 2 Completed

25 enrolled

Gastrointestinal

Liver Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

Clinical Trials

Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System

Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer

Photodynamic Therapy (PDT) With Metvix Cream 160 mg/g Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Cell Carcinoma

Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)

Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp

Intravesical Photodynamic Therapy (PDT) in BCG Refractory High-Risk Non-muscle Invasive Bladder Cancer (NMIBC) Patients

Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)

Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick

Photodynamic Therapy With PD P 506 A Compared With Placebo-PDT for the Treatment of AK

PD P 506 A-PDT Versus Placebo-PDT and Cryosurgery for the Treatment of AK

Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)

Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases

Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases